REVIEW ARTICLE: FAVIPIRAVIR AS AN ANTIVIRAL DRUG
*Minesh D. Patel, Falguni G. Bhabhor and Shivam Pandya
ABSTRACT
Favipiravir is a RNA polymerase inhibitor, has been proved to have potent inhibitory activity against RNA viruses in vitro & in vivo. In recent times it has shown activity against COVID- 19 also. Synthesis routes to Favipiravir can be divided into two categories, with one category being the reactions developed by the innovator Toyama Chemical Company and the other group being reactions developed by academia and generic companies. Favipiravir’s side effects are also discussed in this review. Favipiravir’s efficacy gets varied when interacted with other drugs such as pyrazinamide, repaglinide, theophylline, famciclovir, sulindac and acyclovir.
[Full Text Article] [Download Certificate]